news

« BACK

Pharmacology



Results 1 - 20 of 879.
1 2 3 4 5 ... 44 Next »


Pharmacology - Health - 25.10.2024
Stroke patients could benefit from earlier blood thinning treatment
People with atrial fibrillation (AF) who have a stroke could benefit from blood thinning treatments, known as anticoagulants, at an earlier stage than is currently recommended, finds a new study led by UCL researchers. Results from the British Heart Foundation funded OPTIMAS study are published in the Lancet and presented at the World Stroke Congress 2024.

Health - Pharmacology - 25.10.2024
Most non-cancer pain opioid prescriptions are for musculoskeletal conditions
Most non-cancer pain opioid prescriptions are for musculoskeletal conditions
Nearly three quarters of new non-cancer pain opioid prescriptions were for patients with musculoskeletal conditions, despite limited evidence of the drug's efficacy, according to the largest UK study of its kind. The new study , also the first of its kind in the UK, evaluated the specific clinical conditions that lead to the initiation of opioid prescriptions using data from nationally representative GP electronic health records.

Environment - Pharmacology - 23.10.2024
UK rivers contain cocktail of chemicals, pharmaceuticals and stimulants
A nationwide citizen science project has found high levels of chemical pollutants in freshwater bodies across the UK. Thousands of volunteers have helped to provide a snapshot of the health of the nation's rivers and waterways, highlighting high levels of nitrates and phosphates, as well as a cocktail of chemical compounds that pose a risk to ecosystems.

Pharmacology - Health - 11.10.2024
Typhoid vaccine trial confirms sustained protection for older children
Typhoid vaccine trial confirms sustained protection for older children
A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, and sustained protection for older children at three to five years post immunisation, according to a report by researchers at the Oxford Vaccine Group and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) .

Health - Pharmacology - 10.10.2024
Patients more likely to be admitted to critical care after surgery if a bed is available
Bed availability is a "significant" factor in determining whether or not a patient is admitted to a critical care bed after surgery, questioning whether some are getting the care they need, a new study from researchers at UCL and UCLH has found for the first time. The study, published in Anaesthesia , sought to shed light on how hospital patients are prioritised for postoperative care and what impact that has on their health.

Pharmacology - Health - 27.09.2024
Commonly used drug could transform treatment of rare muscle disorder
Commonly used drug could transform treatment of rare muscle disorder
Lamotrigine, a drug commonly used to treat epilepsy and certain mood disorders, has been shown to be an excellent treatment option for a rare genetic neuromuscular disease known as non-dystrophic myotonia, in a world-first trial led by UCL researchers. The study, published in Lancet Neurology , detailed the "head-to-head" trial implemented by the researchers to test two drugs, mexiletine and lamotrigine, on people with the condition.

Health - Pharmacology - 26.09.2024
A cure for psoriasis: could a faulty iron hormone in the skin be the key?
A cure for psoriasis: could a faulty iron hormone in the skin be the key?
Scientists believe the hormone hepcidin, when produced in the skin, may be the root cause of psoriasis - a chronic disease affecting 2-3% of the population. Scientists may have uncovered the root cause of psoriasis, a chronic and sometimes debilitating skin disease that affects 2-3% of the global population.

Physics - Pharmacology - 20.09.2024
Ultrafast probing and AI-enabled drug discovery: News from Imperial
Here's a batch of fresh news and announcements from across Imperial. From ultrafast probing pulses to a free AI algorithm that could find new medicines more efficiently, here is some quick-read news from across Imperial. W-boson mass measurement   The Standard Model of particle physics - which describes all the subatomic particles and forces we know about - has triumphed again.

Health - Pharmacology - 18.09.2024
Personalised treatment could be key to tackling uncontrolled high blood pressure
A widely used drug could be the key to treating many patients with uncontrolled high blood pressure, particularly for patients with a common gene variant, according to new research led by the University of Glasgow and published in the journal Hypertension. In the British Heart Foundation (BHF) study, people with high blood pressure who had two copies of the variation experienced a five per cent reduction in their average blood pressure after taking the drug torasemide for 16 weeks.

Health - Pharmacology - 16.09.2024
Ignore antifungal resistance in fungal disease at your peril, warn top scientists
Ignore antifungal resistance in fungal disease at your peril, warn top scientists
Without immediate action, humanity will face a potentially disastrous escalation in resistance in fungal disease, a renowned group of scientists from the across the world has warned. The comment piece - published in The Lancet - was coordinated by scientists at The University of Manchester, the Westerdijk Institute and the University of Amsterdam.

Health - Pharmacology - 16.09.2024
Monoclonal antibodies offer hope for tackling antimicrobial resistance
Monoclonal antibodies - treatments developed by cloning a cell that makes an antibody - could help provide an answer to the growing problem of antimicrobial resistance, say scientists.

Health - Pharmacology - 11.09.2024
UCL releases animal research statistics alongside fellow top institutions
UCL releases animal research statistics alongside fellow top institutions
UCL is releasing its animal research statistics today in collaboration with Understanding Animal Research - a non-profit that promotes open communications about animal research. UCL and nine other institutions together conducted over half of all'animal procedures - those used in medical, veterinary, and scientific research - in the UK in 2023.

Health - Pharmacology - 06.09.2024
'Gene silencer' drug shows promise in treating heart condition
’Gene silencer’ drug shows promise in treating heart condition
A drug known as a "gene silencer" has shown promise in reducing hospitalisation and deaths from a devastating condition known as transthyretin (ATTR) cardiac amyloidosis, according to a new study led by UCL researchers.

Health - Pharmacology - 01.09.2024
All types of heart failure may benefit from treatment with MRAs
Mineralocorticoid receptor antagonists (MRAs) reduced the risk of cardiovascular death or heart failure hospitalisation in patients with heart failure and reduced ejection fraction (HFrEF) and also in those with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), according to new research.

Health - Pharmacology - 28.08.2024
Food allergy doubles in the UK over last decade but many still without treatment
The number of people with food allergy in the UK has more than doubled since 2008, with the largest increase seen in young children. In a new analysis, researchers from Imperial College London estimate that the number of people living with food allergies in England has increased significantly between 2008 and 2018.

Health - Pharmacology - 23.08.2024
Weight loss drug's heart benefits extend to people with heart failure
Weight loss drug’s heart benefits extend to people with heart failure
The anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events among overweight people who have cardiovascular disease, whether or not they also have heart failure, according to a new study led by UCL's Professor John Deanfield. The results follow previous research* from the same international team finding that weekly injections of semaglutide were linked to a 20% reduction in major adverse cardiac events (MACE) such as heart attacks and strokes for people with obesity or who were overweight and had cardiovascular disease.

Pharmacology - Health - 21.08.2024
Sex worker study brings effective gonorrhoea vaccine step closer
Sex worker study brings effective gonorrhoea vaccine step closer
A ground-breaking study involving Kenyan sex workers has shone a light into the immune response to gonorrhoea, paving the way for more effective vaccines. Carried out by scientists at the Universities of Manchester and Oxford working in collaboration with the KEMRI/Wellcome Trust Unity in Kenya, The findings come amid recent reports showing Gonorrhoea - a sexually transmitted disease - is becoming increasingly resistant to antibiotics and could become untreatable in the future.

Health - Pharmacology - 16.08.2024
Superbug's rapid path to antibiotic resistance
Superbug’s rapid path to antibiotic resistance
Scientists have discovered how the hospital superbug C.diff rapidly evolves resistance to the frontline drug used for treatment in the UK. Clostridioides difficile (C. diff), a type of bacteria which often affects people who have taken antibiotics, is responsible for approximately 2,000 deaths annually in the UK.

Health - Pharmacology - 15.08.2024
New method could lower radiotherapy doses for some cancer patients
New method could lower radiotherapy doses for some cancer patients
A special type of MRI scan where patients inhale 100% oxygen could result in lower radiotherapy doses for some cancer patients. The study led by scientists at The University of Manchester and The Institute of Cancer Research, London, could potentially benefit patients by using a technique called Oxygen-enhanced magnetic resonance imaging (OE-MRI).

Health - Pharmacology - 14.08.2024
Immune cell regulator discovery could lead to treatments for arthritis and severe COVID
The discovery of new regulator-affecting immune cells could lead to novel treatments to reduce inflammation in diseases, including arthritis and severe COVID-19. The new research, carried out by a large collaboration including researchers at the University of Glasgow, focused on how immune cells sense their environment -activity that triggers responses which are finely balanced, to protect against disease and infection, and to reduce cell-damaging inflammation.
1 2 3 4 5 ... 44 Next »